| - Data published in the scientific journal Investigative Ophthalmology & Visual Science generated by investigators at the Schepens Eye Research Institute led by Harvard University Professor Reza Dana. - VEGF-C markedly up-regulated in corneal graft rejection. - VGX-100 significantly improved corneal graft survival in a mouse corneal graft model. - Data indicates potential opportunity for VGX-100 as a therapeutic for major unmet clinical need of improving corneal graft survival. MELBOURNE, A...continued CKDXY |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Pages
▼
No comments:
Post a Comment